- Home
- TT vs GSK Comparison
TT vs GSK Comparison
Compare TT & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TT
- GSK
- Stock Information
- Founded
- TT 1885
- GSK 1715
- Country
- TT Ireland
- GSK United Kingdom
- Employees
- TT N/A
- GSK N/A
- Industry
- TT Auto Parts:O.E.M.
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- TT Industrials
- GSK Health Care
- Exchange
- TT Nasdaq
- GSK Nasdaq
- Market Cap
- TT 92.5B
- GSK 81.9B
- IPO Year
- TT N/A
- GSK N/A
- Fundamental
- Price
- TT $427.46
- GSK $46.00
- Analyst Decision
- TT Hold
- GSK Buy
- Analyst Count
- TT 12
- GSK 3
- Target Price
- TT $458.92
- GSK N/A
- AVG Volume (30 Days)
- TT 1.2M
- GSK 6.2M
- Earning Date
- TT 10-30-2025
- GSK 10-29-2025
- Dividend Yield
- TT 0.88%
- GSK 3.52%
- EPS Growth
- TT 24.76
- GSK 118.57
- EPS
- TT 12.60
- GSK 1.79
- Revenue
- TT $20,750,100,000.00
- GSK $43,237,357,842.00
- Revenue This Year
- TT $11.43
- GSK $5.50
- Revenue Next Year
- TT $7.53
- GSK $5.21
- P/E Ratio
- TT $33.93
- GSK $25.72
- Revenue Growth
- TT 10.20
- GSK 2.73
- 52 Week Low
- TT $298.15
- GSK $31.72
- 52 Week High
- TT $476.19
- GSK $46.87
- Technical
- Relative Strength Index (RSI)
- TT 56.35
- GSK 69.92
- Support Level
- TT $424.37
- GSK $42.89
- Resistance Level
- TT $437.75
- GSK $46.71
- Average True Range (ATR)
- TT 9.80
- GSK 0.70
- MACD
- TT 0.86
- GSK 0.06
- Stochastic Oscillator
- TT 64.83
- GSK 81.74
About TT Trane Technologies plc
Trane Technologies manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its prominent Trane, American Standard, and Thermo King brands. The $20 billion company generates approximately 70% of its sales from equipment and 30% from parts and services. While the firm is domiciled in Ireland, North America accounts for over 80% of its revenue.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.